We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

190 hedge funds and large institutions have $805M invested in Immunogen Inc in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $18.4M | Put options by funds: $6.38M

9% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 57

7% less funds holding

Funds holding: 204 → 190 (-14)

20% less capital invested

Capital invested by funds: $1B → $805M (-$198M)

32% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 31

Holders
190
Holders Change
-14
Holders Change %
-6.86%
% of All Funds
3.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
62
Reduced
57
Closed
31
Calls
$18.4M
Puts
$6.38M
Net Calls
+$12M
Net Calls Change
+$8.64M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$56.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$27.8M
3
Artisan Partners
Artisan Partners
Wisconsin
+$13.6M
4
Morgan Stanley
Morgan Stanley
New York
+$13.1M
5
Millennium Management
Millennium Management
New York
+$8.71M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$31.5M
2
Jennison Associates
Jennison Associates
New York
-$29.1M
3
WP
Woodline Partners
California
-$24.9M
4
B
Braidwell
Connecticut
-$17.2M
5
GIM
Granahan Investment Management
Massachusetts
-$5.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Handelsbanken Fonder
126
Handelsbanken Fonder
Sweden
$108K – – –
CAPTRUST Financial Advisors
127
CAPTRUST Financial Advisors
North Carolina
$103K -$1.8K -423 -2%
CPIG
128
Chicago Partners Investment Group
Illinois
$103K +$13.1K +3,076 +14%
AB
129
Amalgamated Bank
New York
$100K -$20.2K -4,741 -15%
PAMS
130
Pictet Asset Management (Switzerland)
Switzerland
$99.1K – – –
Victory Capital Management
131
Victory Capital Management
Texas
$96.3K +$1.17K +275 +1%
LB
132
Leo Brokerage
Texas
$96K +$107K +25,000 New
AQR Capital Management
133
AQR Capital Management
Connecticut
$95.1K -$5.96K -1,398 -5%
MAWCM
134
Mine & Arao Wealth Creation & Management
California
$85.4K – – –
JF
135
Jump Financial
Illinois
$83.6K +$33.9K +7,953 +58%
PCM
136
Perkins Capital Management
Minnesota
$83K +$38.4K +9,000 +72%
XT
137
XTX Topco
Cayman Islands
$80.6K -$17.6K -4,133 -16%
CWA
138
CM Wealth Advisors
Ohio
$80K +$80.7K +18,934 New
PI
139
PEAK6 Investments
Illinois
$76.8K +$85.2K +20,000 New
LPL Financial
140
LPL Financial
California
$73.9K +$33.4K +7,829 +69%
TFM
141
TFC Financial Management
Massachusetts
$68.9K – – –
Northwestern Mutual Wealth Management
142
Northwestern Mutual Wealth Management
Wisconsin
$64.4K +$64 +15 +0.1%
Mackenzie Financial
143
Mackenzie Financial
Ontario, Canada
$63.9K -$380K -89,250 -84%
Jane Street
144
Jane Street
New York
$63.9K -$223K -52,256 -76%
SC
145
Scotia Capital
Ontario, Canada
$62.2K – – –
AIP
146
Ameritas Investment Partners
Nebraska
$60.1K – – –
KeyBank National Association
147
KeyBank National Association
Ohio
$59K -$73.1K -17,159 -53%
Lazard Asset Management
148
Lazard Asset Management
New York
$58K +$64.9K +15,232 New
X
149
Xponance
Pennsylvania
$47.1K – – –
TRCT
150
Tower Research Capital (TRC)
New York
$47K -$153K -35,849 -75%
4 5
6
7 8

IMGN Hedge Fund Activity: Q1 2023 in Review

190 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2023, worth a combined $805M — down 20% from $1B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of IMGN and 21 opened new positions — a net loss of 10 holders — while 57 trimmed existing stakes and 62 added.

The largest buyer was Janus Henderson Group, adding an estimated $56.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $31.5M sold.

  • 190 institutional investors held Immunogen Inc (IMGN) as of Q1 2023, down from 204 in Q4 2022.
  • Funds reported $805M of Immunogen Inc stock for Q1 2023, down 20% quarter-over-quarter.
  • 21 funds opened new Immunogen Inc positions in Q1 2023 and 31 closed out, a net change of -10 holders.
  • The largest Immunogen Inc buyer in Q1 2023 was Janus Henderson Group, an estimated $56.7M added.
  • The largest Immunogen Inc seller in Q1 2023 was Deerfield Management, an estimated $31.5M sold.

Based on aggregated 13F filings for Q1 2023.